The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I'm holding on. This looks like it may have legs. But my time horizon may be longer than some. Don't forget that this was over 300p in 2020 and near 600p in 2011. Buy and hold for me, but each to their own.
Cj, I suggest you read the thread:
Moon: "Well there is mention of covid lockdown again if it happen price gold silver go though the roof"
You: "Moon. It didn't in 2020. Why would it now?"
Me: "Cj, in fairness to Mr Moon, silver more than doubled between March 2020 and September 2020, and gold added roughly 35% in that time, also. A UK-wide lockdown was announced on 23rd March, 2020."
You: "Glen 'silver more than doubled between March 2020 and September 2020'. 2020 was the peak of the lock down. Silver doubled during that period."
I fail to see your point. You're just reiterating what I said, but insinuating I'm somehow wrong. All very bizarre. Keep taking the tablets, cj!
Cj, in fairness to Mr Moon, silver more than doubled between March 2020 and September 2020, and gold added roughly 35% in that time, also. A UK-wide lockdown was announced on 23rd March, 2020.
...is when there's blood in the streets." Well, after the recent carnage, are we there yet?
This is all well and good, but the market remains underwhelmed. Does anyone know the likely terms of the agreement? Will it involve yet more dilution? Plus, this bit in the RNS seems to contradict itself:
"The pricing submitted by REGROUP's bid supports:
o The potential for capital savings when compared to those forecasted in the scoping study; and
o It is consistent with the assumptions made by the Scoping Study to deliver direct cost of production of approximately US$60 per tonne". Either there are capital savings (compared to the scoping study forecast), or the cost is consistent with what the scoping study assumed. You can't have it both ways, surely, or am I being thick?
Silver catching a bid today (up nearly 3% in GBP terms). Also, the BRICS summit (22nd-24th) may throw up some surprises? In addition, the bond market imploding should be good for gold? Probably other reasons, too.
Dickie, normally I would agree with you. But I think many LTHs here are so far under water that selling now would be counter-productive. Moreover, I think they do have every right to question the integrity of the board, given the missed deadlines and broken assurances, and continued cash calls, that collectively dilute the real supporters of UFO who, frankly, deserve better.
Sflf, I guess this morning's RNS answers your question: "Full safety data from the Phase 1a trial are expected to be available during the first half of 2024 and, provided satisfactory results continue to be obtained, and funding is available under the RiverFort Equity Prepayment Facility or otherwise, a Phase 1b clinical study is expected to commence as soon as possible thereafter in psoriasis patients, with a readout expected before the end of 2024, subject to recruitment and progress."
May the Lord be with you, Bish. You certainly must possess almighty cojones...
"Physician heal thyself"? Pompous twat.
Mr Magoo?
Apologies if this has already been covered, but what happened to the "there is a key Native Title meeting scheduled in July" (from the Financial Results RNS of 30th June)? Has is happened? Was it re-scheduled? Anyone? Starting to get a tad unnerved by the missed deadlines and poor comms. I do think shareholders have a right to know if there are delays to published timelines, even if the delays are not of UFO's making. A little more transparency would be nice.
Wasn't it Mao who said: "The more one reads, the stupider one becomes"? I think @tacet is living proof of that particular maxim.
...on days like today often reveal the true story. Do they, for example, indicate a wholesale exodus? No. I know the buy/sell figures on this website are unreliable, but the volume of shares (whether bought or sold - who's counting?) suggests only around 5% of shares in issue have exchanged hands, so far. Yet we're down 32%? That seems an overreaction, surely? At these levels, you'll likely make 25% return in short order as the market comes to its senses. And delays/"additional information required" are really not uncommon when trialling new drugs. I expect this to be a storm in a teacup and anything requiring further detail to be clarified forthwith. Markets hate uncertainty/surprises. I get it. But invariably the market has its hissy fit, realizes it overreacted, and boom, we're back to 2p awaiting news.
Porky9, it's the way in which he/she has changed his/her user name (it's been Laura2022, Investor1978, and of course Riddler) to disguise his/her real agenda. He/She pumped here and on the DMTR board (where investors lost everything). He/She vilified me when I suggested a couple of years ago that I thought PYC was going the same way as DMTR (the share price was then around 7p when I bailed). Anyone who questioned the profitability/validity of PYC's business model was mocked and derided, labelled "clueless". You just have to look back at Riddler's comments, in particular, to see what I mean. Anyway, I'm sorry for holders here. I was once a believer but I'm afraid this is looking terminal from here. Salvage what you can.
Rugs, 4m shares is actually less than 0.1% of shares in issue, yet we're down 6.38%. MM scare tactics, perhaps?
I'm sorry. Perhaps try with a small 'h' :
https://www.thisismoney.co.uk/money/markets/article-12080419/Close-Brothers-hit-hedge-fund-short-selling.html
The Fed hiking interest rates would normally be bullish for the dollar (and hence bearish for commodities). But not anymore. The US banking system is collapsing, the contagion is spreading, and people are running for the hills (into commodities). Just my opinion, but beware holding too much cash in the bank, and certainly no more than the government insures.
Feeling blue?